Natalizumab shortage

As of 2 Nov 2026, Natalizumab has a reported shortage in 1 of the 16 countries we track (Czechia), covering 1 product from 1 company.

Is there a Natalizumab shortage?

Yes. As of 2 Nov 2026, Natalizumab is reported short in 1 of the 16 countries we track: Czechia. The earliest expected return is 15 Jan 2027 (Czechia). New since 3 Oct 2026: Czechia.

Countries1/16

Products1packs or presentations

Companies11 listed

Short since29 Oct 20264 days ago

Earliest return15 Jan 2027company estimate

Main reasonManufacturing problem

Timeline

Czechia

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries

Listed: Sandoz SDZ · SIX Swiss

Affected products

Country	Product	Company	Since	Expected back	Reason
CZ	TYRUKO 300MG 300MG INF CNC SOL 1X15ML	Sandoz GmbH, Kundl	29 Oct 2026	15 Jan 2027	Manufacturing problem Výrobní důvody

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there a Natalizumab shortage?

Yes. As of 2 Nov 2026, Natalizumab is reported short in 1 of the 16 countries we track: Czechia. The earliest expected return is 15 Jan 2027 (Czechia). New since 3 Oct 2026: Czechia.

When will Natalizumab be back in stock?

Companies expect supply back from 15 Jan 2027 in Czechia; Czechia: 15 Jan 2027. These are company estimates reported to each authority.

Why is Natalizumab in short supply?

The most common reason reported is: manufacturing problem. Reasons by product are listed in the table below.

Which companies have Natalizumab shortages?

Sandoz.